153 related articles for article (PubMed ID: 35791295)
1. Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials.
Diaz P; Reddy R; Blachman-Braun R; Zucker I; Dullea A; Gonzalez DC; Kresch E; Ramasamy R
World J Mens Health; 2023 Apr; 41(2):390-395. PubMed ID: 35791295
[TBL] [Abstract][Full Text] [Related]
2. Serum 17-Hydroxyprogesterone is a Potential Biomarker for Evaluating Intratesticular Testosterone.
Lima TFN; Patel P; Blachman-Braun R; Madhusoodanan V; Ramasamy R
J Urol; 2020 Sep; 204(3):551-556. PubMed ID: 32167868
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of secondary erythrocytosis in men receiving testosterone therapy A matched-cohort analysis of intranasal gel, injections, and pellets.
Reddy R; Diaz P; Blachman-Braun R; Loloi J; Rahman F; Ory J; Dullea A; Zucker I; Gonzalez DC; Kresch E; Ramasamy R
Can Urol Assoc J; 2023 Jul; 17(7):E202-E207. PubMed ID: 37068153
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
Rivero MJ; Ory J; Diaz P; Thirumavalavan N; Han S; Reis IM; Ramasamy R
J Urol; 2023 Jul; 210(1):162-170. PubMed ID: 37126399
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate.
Choi EJ; Xu P; Barham D; El-Khatib FM; Yafi FA; Kavoussi PK
J Urol; 2022 Mar; 207(3):677-683. PubMed ID: 34694927
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Increase Testosterone in Men Seeking Fertility.
Chu KY; Achua JK; Ramasamy R
Urol Res Pract; 2023 Jan; 49(1):2-6. PubMed ID: 33085606
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
Mechlin CW; Frankel J; McCullough A
J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a serum 17-hydroxyprogesterone as a predictor of semen parameter improvement in men undergoing medical treatment for infertility.
Lima TFN; Rakitina E; Blachman-Braun R; Ramasamy R
Can Urol Assoc J; 2021 Jul; 15(7):E340-E345. PubMed ID: 33382370
[TBL] [Abstract][Full Text] [Related]
9. Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone?
Patel A; Patel P; Bitran J; Ramasamy R
Transl Androl Urol; 2019 Mar; 8(Suppl 1):S58-S63. PubMed ID: 31143672
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Using 17-OHP as Serum Biomarker to Monitor Therapy in Patients With Hypogonadotropic Hypogonadism.
Mouzannar A; Narasimman M; Patel P; Ramasamy R
Rev Urol; 2019; 21(4):180-182. PubMed ID: 32071569
[TBL] [Abstract][Full Text] [Related]
12. Association of aging and obesity with decreased 17-hydroxyprogesterone, a serum biomarker of intratesticular testosterone.
Lima TFN; Frech FS; Blachman-Braun R; Rakitina E; Patel P; Ramasamy R
Int J Impot Res; 2022 Jan; 34(1):44-49. PubMed ID: 33009497
[TBL] [Abstract][Full Text] [Related]
13. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial.
Ramasamy R; Masterson TA; Best JC; Bitran J; Ibrahim E; Molina M; Kaiser UB; Miao F; Reis IM
J Urol; 2020 Sep; 204(3):557-563. PubMed ID: 32294396
[TBL] [Abstract][Full Text] [Related]
14. Natesto™ , a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men.
Rogol AD; Tkachenko N; Bryson N
Andrology; 2016 Jan; 4(1):46-54. PubMed ID: 26695758
[TBL] [Abstract][Full Text] [Related]
15. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
[TBL] [Abstract][Full Text] [Related]
16. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
[TBL] [Abstract][Full Text] [Related]
17. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
18. Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels.
Lima TFN; Frech FS; Patel P; Blachman-Braun R; Ramasamy R
BJUI Compass; 2020 Jul; 1(3):93-99. PubMed ID: 32661515
[TBL] [Abstract][Full Text] [Related]
19. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
